• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » UPDATE: Medtronic finally unloads Physio-Control

UPDATE: Medtronic finally unloads Physio-Control

November 17, 2011 By MassDevice staff

Medtronic

Less than a month after new CEO Omar Ishrak signaled Medtronic’s (NYSE:MDT) continued interest in selling its troublesome Physio-Control resuscitation business, the company found a buy ready to put nearly half a billion dollars on the table: private equity firm Bain Capital.

Medtronic said it’s agreed to a cash offer worth roughly $487 million for Physio-Control, which it’s been trying to unload for years. Plagued by recalls in 2009 and 2010, the division was a tough sell until February 2010, when the FDA lifted a consent decree barring worldwide shipments of automated external defibrillators.

Last month Ishrak said the company had no plans to spin out any businesses, except for Physio-Control. Medtronic has been shopping the business since 2006, saying it would do better as a stand-alone operation. But Physio-Control has been a headache since the company first announced its desire to sell, due to the series of recalls.

Sign up to get our free newsletters delivered right to your inbox

Medtronic said it expects to use a portion of Bain deal’s proceeds to offset its impact on its fiscal 2012 earnings. Current president Brian Webster will stay on to lead the business as CEO after the deal closes, expected during the first quarter of 2012.

"We are pleased that Physio-Control has found another strong partner to prepare the company for the next stage of its growth," Ishrak said in prepared remarks. "For more than 55 years, Physio-Control has been developing technologies and designing devices that are legendary among emergency medical response professionals. With an impressive innovation pipeline and backing by Bain Capital, we believe Physio-Control will be well-positioned for growth and to continue its lifesaving mission to serve emergency responders, hospital care teams and their patients around the world."

At least one Wall Street house viewed the move as a plus for Medtronic.

"While the sale isn’t likely to come as a surprise to most investors, we believe this news does remove an overhang on MDT shares," Leerink Swann analyst Rick Wise wrote in a note to investors.

The rest of The Street remains unimpressed. MDT shares were down 2.3 percent today to $33.43 as of about 1:40 p.m.

Filed Under: Mergers & Acquisitions, News Well Tagged With: Bain Capital, Cardiac Rhythm Management, physiocontrol, Resuscitation

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy